syndrome. Broad screening for cytokine storm and early, targeted antiinflammatory therapy
may prevent immunopathology and could help conserve limited health care resources.
While studies are ongoing, extrapolating from clinical experience in cytokine storm
syndromes may benefit the multidisciplinary teams caring for patients with severe COVID‐
19.